Related references
Note: Only part of the references are listed.Extrapolating Parametric Survival Models in Health Technology Assessment: A Simulation Study
Daniel Gallacher et al.
MEDICAL DECISION MAKING (2021)
Extrapolating Parametric Survival Models in Health Technology Assessment Using Model Averaging: A Simulation Study
Daniel Gallacher et al.
MEDICAL DECISION MAKING (2021)
Properties of the bridge sampler with a focus on splitting the MCMC sample
Jackie S. T. Wong et al.
STATISTICS AND COMPUTING (2020)
Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force
Claire Rothery et al.
VALUE IN HEALTH (2020)
Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies
Anna Heath et al.
MEDICAL DECISION MAKING (2020)
A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis
Laura Flight et al.
VALUE IN HEALTH (2019)
Expert Knowledge Elicitation: Subjective but Scientific
Anthony O'Hagan
AMERICAN STATISTICIAN (2019)
A Review of Issues Affecting the Efficiency of Decision Making in the NICE Single Technology Appraisal Process
M. J. Walton et al.
PHARMACOECONOMICS-OPEN (2019)
Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods
Christopher Jackson et al.
MEDICAL DECISION MAKING (2017)
A tutorial on bridge sampling
Quentin F. Gronau et al.
JOURNAL OF MATHEMATICAL PSYCHOLOGY (2017)
Assessing the Expected Value of Research Studies in Reducing Uncertainty and Improving Implementation Dynamics
Sabine E. Grimm et al.
MEDICAL DECISION MAKING (2017)
The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment
Sabine Elisabeth Grimm et al.
PHARMACOECONOMICS (2017)
A Comprehensive Algorithm for Approval of Health Technologies With, Without, or Only in Research: The Key Principles for Informing Coverage Decisions
Karl Claxton et al.
VALUE IN HEALTH (2016)
Estimating the Expected Value of Sample Information Using the Probabilistic Sensitivity Analysis Sample: A Fast, Nonparametric Regression-Based Method
Mark Strong et al.
MEDICAL DECISION MAKING (2015)
Unifying Research and Reimbursement Decisions: Case Studies Demonstrating the Sequence of Assessment and Judgments Required
Claire McKenna et al.
VALUE IN HEALTH (2015)
Estimating Multiparameter Partial Expected Value of Perfect Information from a Probabilistic Sensitivity Analysis Sample: A Nonparametric Regression Approach
Mark Strong et al.
MEDICAL DECISION MAKING (2014)
Survival Analysis for Economic Evaluations Alongside Clinical Trials-Extrapolation with Patient-Level Data: Inconsistencies, Limitations, and a Practical Guide
Nicholas R. Latimer
MEDICAL DECISION MAKING (2013)
Optimal Global Value of Information Trials: Better Aligning Manufacturer and Decision Maker Interests and Enabling Feasible Risk Sharing
Simon Eckermann et al.
PHARMACOECONOMICS (2013)
Value of Information and Pricing New Healthcare Interventions
Andrew R. Wilan et al.
PHARMACOECONOMICS (2012)
DANGEROUS OMISSIONS: THE CONSEQUENCES OF IGNORING DECISION UNCERTAINTY
Susan C. Griffin et al.
HEALTH ECONOMICS (2011)
A Framework for Addressing Structural Uncertainty in Decision Models
Christopher H. Jackson et al.
MEDICAL DECISION MAKING (2011)
Stochastic model specification search for Gaussian and partial non-Gaussian state space models
Sylvia Fruehwirth-Schnatter et al.
JOURNAL OF ECONOMETRICS (2010)
Structural and parameter uncertainty in Bayesian cost-effectiveness models
Christopher H. Jackson et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2010)
Comparative Effectiveness, Personalized Medicine and Innovation The Path Forward
Adrian Thomas et al.
PHARMACOECONOMICS (2010)
The Value of Value of Information Best Informing Research Design and Prioritization Using Current Methods
Simon Eckermann et al.
PHARMACOECONOMICS (2010)
GLOBALLY OPTIMAL TRIAL DESIGN FOR LOCAL DECISION MAKING
Simon Eckermann et al.
HEALTH ECONOMICS (2009)
Accounting for uncertainty in health economic decision models by using model averaging
Christopher H. Jackson et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2009)
The option value of delay in health technology assessment
Simon Eckermann et al.
MEDICAL DECISION MAKING (2008)
The generalized F distribution:: An umbrella for parametric survival analysis
Christopher Cox
STATISTICS IN MEDICINE (2008)
Expected value of sample information calculations in medical decision modeling
AE Ades et al.
MEDICAL DECISION MAKING (2004)
Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data
AR Willan et al.
HEALTH ECONOMICS (2004)
Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
P Royston et al.
STATISTICS IN MEDICINE (2002)
Share Paper
